AVITA Medical, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +1.0%
EBITDA: +25.1%
EBIT: +22.8%
EPS: —
Free cash flow: +34.2%
Operating cash flow: +19.3%

Forward estimates

Revenue: +1.7%
EBITDA: -39.5%
EPS: +99.4%

Three-year CAGR

Revenue: +27.7%
EBITDA: +25.5%
EBIT: +24.8%
Net income: +21.4%
EPS: +27.2%
Free cash flow: +43.5%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.